Neo-angin® (Neo-angin®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceAmylmetacresol + Dichlorobenzyl alcohol + LevomentolAmylmetacresol + Dichlorobenzyl alcohol + Levomentol
Similar drugsTo uncover
  • Neo-angin®
    pills locally 
    Divafarma GmbH     Germany
  • Neo-angin®
    pills locally 
    Divafarma GmbH     Germany
  • Strepsils® with menthol and eucalyptus
    pills locally inwards 
    Rekitt Benckiser Helsar International Ltd.     United Kingdom
    • Dosage form: & nbspTabletki for resorption.
    Composition:

    1 tablet for resorption contains:

    Active substances: dichlorobenzyl alcohol 1.20 mg, amyl methacresol 0.60 mg, levomentol 5.90 mg.

    Excipients: anise of stellate fruit oil 2.50 mg, peppermint mint oil 0.60 mg, sucrose 1422.70 mg, glucose syrup 1138.15 mg, tartaric acid 28.00 mg, crimson dye (Ponso 4R) 0.35 mg

    Description:

    Round, slightly biconcave tablets with a rough surface red color with a characteristic smell. Allowed uneven staining, the presence of air bubbles in the caramel mass and a slight unevenness of the edges. Occurrence of a white touch is possible.

    Pharmacotherapeutic group:antiseptic
    ATX: & nbsp

    R.02.A.A   Antiseptics

    Pharmacodynamics:

    Combined antiseptic preparation for topical application in the oral cavity and pharynx.

    It is active against gram-positive and gram-negative microorganisms and fungi.

    Pharmacokinetics:Due to low systemic absorption, there is no data on the pharmacokinetics of NEOANGIN®.
    Indications:Prevention and treatment of infectious and inflammatory diseases of the oral cavity and pharynx (pharyngitis, laryngitis, uncombed forms of angina, stomatitis, gingivitis).
    Contraindications:

    Hypersensitivity to the components of the drug.

    Children under 6 years.

    Dosing and Administration:

    Adults and children over 6 years of age are prescribed 1 tablet every 2-3 hours. The maximum daily dose is 8 tablets.

    Tablets dissolve until complete dissolution.

    Side effects:

    Allergic reactions, dyspepsia are possible.

    Overdose:Not described.
    Interaction:

    Clinically significant interaction of the drug NEO-ANGIN® with drugs of other groups was not detected.

    Special instructions:

    When prescribing a drug for patients with diabetes it is necessary to take into account that 1 tablet corresponds to 0.22 XE.

    Form release / dosage:

    Lozenges.

    Packaging:

    For 8 or 12 tablets in a contour mesh box made of PVC-PVDC / AL foil (blister).

    2 blisters with 8 tablets or 2 or 4 blisters with 12 tablets together with instructions for use in a cardboard package.

    Storage conditions:

    In a dry place, at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N 013046/01
    Date of registration:01.10.2007 / 23.06.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:Divafarma GmbHDivafarma GmbH Germany
    Manufacturer: & nbsp
    Representation: & nbspEmSiEl-Pharma, LLCEmSiEl-Pharma, LLC
    Information update date: & nbsp03.12.2016
    Illustrated instructions
      Instructions
      Up